MEDNAX Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Hi, everyone. I'm A.J. Rice, the health care service analyst at Credit Suisse. We're very pleased to have up next presenting at the conference, MEDNAX. We're joined today by Mark Ordan, the CEO of MEDNAX. We've got Dr. Jim Swift, Chief Development Officer; and Charlie Lynch, who heads up Investor Relations for MEDNAX. We appreciate you guys participating, once again, in our conference this year.
Questions & Answers
© -
And I guess just to start off, we're off the heels of the third quarter release. And in the context of that release, you guys anticipate -- updated your outlook for this year, $250 million of EBITDA. Say that you expect to exceed $270 million next year. When you think about that puts and takes, especially for next year, what are the open questions, if there are open questions that would finalize that guidance, where are the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
